Cosponsor
Sign in

S 1095 · introduced · major

Stop STALLING Act

What this bill does

  • The bill makes it illegal to file frivolous petitions to the FDA to block a competitor's drug approval.
  • Pharmaceutical companies and individuals who submit baseless petitions to delay generic drugs are affected.
  • The FTC can sue violators and impose fines up to $50,000 per day the FDA spent reviewing the petition.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

  1. 01

    How would regulators distinguish between a genuinely concerned safety petition and a frivolous delay tactic filed by a competitor?

  2. 02

    What evidence shows that baseless petitions are currently causing significant delays in generic drug approvals and patient access?

  3. 03

    Could $50,000 daily fines deter smaller companies or patient advocacy groups from raising legitimate safety concerns about drug approvals?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · D-MN

Amy Klobuchar

Citizen cosponsors

0

In Congress

6/ 100

Senators cosponsoring

Introduced 2025-04-10

Joining the bill

Legislative timeline

  1. 2025-04-10 · senate · Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

  2. 2025-04-10 · senate · Committee

    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

  3. 2025-04-10 · Committee

    Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

  4. 2025-04-03 · senate · Committee

    Committee on the Judiciary. Ordered to be reported without amendment favorably.

  5. 2025-03-24 · senate · IntroReferral

    Read twice and referred to the Committee on the Judiciary.

  6. 2025-03-24 · IntroReferral

    Introduced in Senate

Congress.gov ↗

Citizen comments

Sign in to comment on this bill.

No comments yet — be the first.